1. Home
  2. AIRE vs ABVC Comparison

AIRE vs ABVC Comparison

Compare AIRE & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo reAlpha Tech Corp.

AIRE

reAlpha Tech Corp.

HOLD

Current Price

$0.29

Market Cap

56.9M

Sector

N/A

ML Signal

HOLD

Logo ABVC BioPharma Inc.

ABVC

ABVC BioPharma Inc.

HOLD

Current Price

$1.34

Market Cap

50.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIRE
ABVC
Founded
2021
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
56.9M
50.5M
IPO Year
2023
2009

Fundamental Metrics

Financial Performance
Metric
AIRE
ABVC
Price
$0.29
$1.34
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$2.00
N/A
AVG Volume (30 Days)
1.3M
57.2K
Earning Date
05-18-2026
06-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
7.14
EPS
N/A
N/A
Revenue
$948,420.00
$509,589.00
Revenue This Year
$470.21
$735.18
Revenue Next Year
$143.58
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.14
$0.61
52 Week High
$1.55
$4.02

Technical Indicators

Market Signals
Indicator
AIRE
ABVC
Relative Strength Index (RSI) 33.00 32.84
Support Level $0.14 $1.15
Resistance Level $0.35 $1.52
Average True Range (ATR) 0.02 0.11
MACD 0.00 0.01
Stochastic Oscillator 4.05 32.36

Price Performance

Historical Comparison
AIRE
ABVC

About AIRE reAlpha Tech Corp.

ReAlpha Tech Corp is a real estate technology company. The group is engaged in an end-to-end commission-free homebuying platform. It develops and utilizes its artificial intelligence-focused technology stack to empower retail investor participation in short-term rental properties, which are real estate units listed for a rental term. It provides short-term rental investment opportunities to everyday investors. The company has developed technologies and tools that allow for the analysis of short-term rental properties using AI to provide insight into that property's potential profitability and ways to increase such profitability. The company's reportable segments are; Platform Services and the Rental business segment.

About ABVC ABVC BioPharma Inc.

ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.

Share on Social Networks: